Expect Equity LLC Makes New Investment in InfuSystem Holdings, Inc. $INFU

Expect Equity LLC purchased a new position in InfuSystem Holdings, Inc. (NYSE:INFU) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 184,819 shares of the company’s stock, valued at approximately $1,784,000. Expect Equity LLC owned 0.92% of InfuSystem as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. BlackRock Inc. bought a new position in InfuSystem during the second quarter worth $15,299,000. Minerva Advisors LLC grew its holdings in InfuSystem by 5.2% during the 4th quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock worth $9,676,000 after acquiring an additional 52,942 shares during the period. Vanguard Group Inc. raised its position in shares of InfuSystem by 1.9% in the 3rd quarter. Vanguard Group Inc. now owns 976,177 shares of the company’s stock worth $10,113,000 after acquiring an additional 18,539 shares in the last quarter. Punch & Associates Investment Management Inc. lifted its stake in shares of InfuSystem by 1.6% in the 1st quarter. Punch & Associates Investment Management Inc. now owns 837,925 shares of the company’s stock valued at $7,734,000 after purchasing an additional 13,175 shares during the period. Finally, Heartland Advisors Inc. bought a new stake in shares of InfuSystem during the 2nd quarter valued at about $6,755,000. 71.13% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, B. Riley Financial reaffirmed a “buy” rating and set a $20.00 target price (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.67.

InfuSystem Trading Up 0.6%

NYSE INFU opened at $12.02 on Wednesday. The company has a market cap of $242.59 million, a price-to-earnings ratio of 200.37 and a beta of 1.42. InfuSystem Holdings, Inc. has a 52 week low of $7.29 and a 52 week high of $12.97. The business has a 50 day moving average price of $10.30 and a 200-day moving average price of $9.59. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50.

InfuSystem declared that its board has authorized a share repurchase plan on Tuesday, May 19th that allows the company to repurchase $20.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 10.2% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.